Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Diabetes Care. 2012 Feb;35(2):409-14. doi: 10.2337/dc11-0996. Epub 2011 Dec 16.
The aim of this study was to examine the relationship between frequent and unrecognized hypoglycemia and mortality in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study cohort.
A total of 10,096 ACCORD study participants with follow-up for both hypoglycemia and mortality were included. Hazard ratios (95% CIs) relating the risk of death to the updated annualized number of hypoglycemic episodes and the updated annualized number of intervals with unrecognized hypoglycemia were obtained using Cox proportional hazards regression models, allowing for these hypoglycemia variables as time-dependent covariates and controlling for the baseline covariates.
Participants in the intensive group reported a mean of 1.06 hypoglycemic episodes (self-monitored blood glucose <70 mg/dL or <3.9 mmol/L) in the 7 days preceding their regular 4-month visit, whereas participants in the standard group reported an average of 0.29 episodes. Unrecognized hypoglycemia was reported, on average, at 5.8% of the intensive group 4-month visits and 2.6% of the standard group visits. Hazard ratios for mortality in models including frequency of hypoglycemic episodes were 0.93 (95% CI 0.9-0.97; P < 0.001) for participants in the intensive group and 0.98 (0.91-1.06; P = 0.615) for participants in the standard group. The hazard ratios for mortality in models, including unrecognized hypoglycemia, were not statistically significant for either group.
Recognized and unrecognized hypoglycemia was more common in the intensive group than in the standard group. In the intensive group of the ACCORD study, a small but statistically significant inverse relationship of uncertain clinical importance was identified between the number of hypoglycemic episodes and the risk of death among participants.
本研究旨在探讨频繁且未被识别的低血糖与 ACTION 研究队列心血管风险控制中的糖尿病(ACCORD)研究参与者的死亡率之间的关系。
共纳入 10096 名接受低血糖和死亡率随访的 ACCORD 研究参与者。使用 Cox 比例风险回归模型获得与死亡风险相关的风险比(95%CI),这些模型与低血糖相关,作为时间依赖性协变量,并控制了基线协变量。
强化组的参与者在常规 4 个月就诊前的 7 天内报告了平均 1.06 次低血糖发作(自我监测血糖<70mg/dL 或<3.9mmol/L),而标准组的参与者平均报告了 0.29 次。强化组的参与者平均有 5.8%的 4 个月就诊报告未被识别的低血糖,而标准组的参与者平均有 2.6%。包括低血糖发作频率的模型中,强化组的死亡率风险比为 0.93(95%CI 0.9-0.97;P<0.001),标准组的死亡率风险比为 0.98(0.91-1.06;P=0.615)。包括未被识别的低血糖的模型中,两组的死亡率风险比均无统计学意义。
强化组参与者的识别和未识别低血糖比标准组更常见。在 ACCORD 研究的强化组中,参与者低血糖发作次数与死亡风险之间存在一种小但具有统计学意义的、不确定的临床重要性的负相关关系。